DE3852105T2 - Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe. - Google Patents

Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.

Info

Publication number
DE3852105T2
DE3852105T2 DE3852105T DE3852105T DE3852105T2 DE 3852105 T2 DE3852105 T2 DE 3852105T2 DE 3852105 T DE3852105 T DE 3852105T DE 3852105 T DE3852105 T DE 3852105T DE 3852105 T2 DE3852105 T2 DE 3852105T2
Authority
DE
Germany
Prior art keywords
aprotinin
yeast
production
homologen
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3852105T
Other languages
English (en)
Other versions
DE3852105D1 (de
Inventor
Kjeld Norris
Fanny Norris
Soren Erik Bjorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE3852105D1 publication Critical patent/DE3852105D1/de
Application granted granted Critical
Publication of DE3852105T2 publication Critical patent/DE3852105T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE3852105T 1987-08-28 1988-08-26 Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe. Expired - Fee Related DE3852105T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK450187A DK450187D0 (da) 1987-08-28 1987-08-28 Fremgangsmaade til fremstilling af proteiner
PCT/DK1988/000138 WO1989001968A1 (en) 1987-08-28 1988-08-26 Aprotinin homologues and process for the production of aprotinin and aprotinin homologues in yeast

Publications (2)

Publication Number Publication Date
DE3852105D1 DE3852105D1 (de) 1994-12-15
DE3852105T2 true DE3852105T2 (de) 1995-03-23

Family

ID=8134111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3852105T Expired - Fee Related DE3852105T2 (de) 1987-08-28 1988-08-26 Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.

Country Status (8)

Country Link
EP (1) EP0375718B1 (de)
JP (1) JP2806958B2 (de)
AT (1) ATE113986T1 (de)
DE (1) DE3852105T2 (de)
DK (1) DK450187D0 (de)
FI (1) FI104428B (de)
NO (1) NO177967C (de)
WO (1) WO1989001968A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
US7413537B2 (en) 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
US5258302A (en) * 1990-07-03 1993-11-02 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA for expression of aprotinin in methylotrophic yeast cells
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
JP4146512B2 (ja) 1991-03-01 2008-09-10 ダイアックス コープ． 小型タンパク質
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben

Also Published As

Publication number Publication date
EP0375718A1 (de) 1990-07-04
EP0375718B1 (de) 1994-11-09
WO1989001968A1 (en) 1989-03-09
FI104428B (fi) 2000-01-31
NO900920D0 (no) 1990-02-27
ATE113986T1 (de) 1994-11-15
JP2806958B2 (ja) 1998-09-30
DK450187D0 (da) 1987-08-28
NO900920L (no) 1990-04-25
FI900991A0 (fi) 1990-02-27
NO177967B (no) 1995-09-18
DE3852105D1 (de) 1994-12-15
JPH03502519A (ja) 1991-06-13
NO177967C (no) 1995-12-27

Similar Documents

Publication Publication Date Title
DE3856265D1 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
CA2005502A1 (en) Somatotropin analogs
HU9200548D0 (en) Improved activity process of recombined proteins
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
SE8801701D0 (sv) Production technology based on enzymic method
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
DE69018926D1 (de) Vakzine gegen Bordetella.
FI99211B (fi) Menetelmä hirudiinivariantin valmistamiseksi
DE68917154T2 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DE69032323D1 (de) Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
GR78453B (de)
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
DE69018307T2 (de) Verfahren zur Herstellung von Kontakten in Halbleiterbauelementen.
DE3884261D1 (de) Verfahren zur Herstellung von Fremdproteinen in Streptomyceten.
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DK51990A (da) Aprotininhomologer og fremgangsmaade til fremstilling af aprotinin og aprotininhomologer i gaer
ATE199556T1 (de) Verfahren zur fraktionierung von deacylierten glycerophospholipiden
ZA91752B (en) Process for the enzymatic cleavage or recombinant proteins using iga proteases
DE59408965D1 (de) Verfahren zur Herstellung langzeitstabiler klarer Seren
DE68909397T2 (de) Verfahren zur Steigerung des Wachstums von Hefe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee